Masumeh Darai
Overview
Explore the profile of Masumeh Darai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darai M, Soleimanian S, Yaghobi R, Kazemi K, Nikeghbalian S, Azarpira N
Iran J Immunol
. 2022 Dec;
19(4):404-413.
PMID: 36585882
Background: Cytomegalovirus (CMV) reinfection in transplant patients has been associated with graft loss and decreased patient survival. In this regard, the HLA-G molecule has the immunomodulatory characteristic and its soluble...
2.
Moini M, Azarpira N, Darai M, Sabet S, Geramizadeh B
Middle East J Dig Dis
. 2015 Nov;
7(4):261-2.
PMID: 26609357
No abstract available.
3.
Azarpira N, Kazemi K, Darai M
Saudi J Kidney Dis Transpl
. 2014 Nov;
25(6):1160-5.
PMID: 25394431
Reperfusion injury predisposes the kidney allograft to acute rejection. Apoptosis is a mechanism that results in graft injury, and TP53 is an important involved gene. To determine the association between...
4.
Parvizi Z, Azarpira N, Kohan L, Darai M, Kazemi K, Parvizi M
Mol Biol Rep
. 2014 Jul;
41(9):6063-9.
PMID: 24996284
New-onset diabetes after transplantation (NODAT) is an important complication after solid organ transplantation. NODAT is a polygenic disease and KCNJ11 E23K polymorphism is considered as a diabetes-susceptibility gene. The present...
5.
Azarpira N, Aghdaie M, Kazemi K, Geramizadeh B, Darai M
Dis Markers
. 2014 Mar;
2014:814182.
PMID: 24591768
Background: HLA-G molecules exhibit immunomodulatory properties that can delay graft rejection. The 14 bp insertion/deletion polymorphism (INDEL) (rs16375) influences the stability of final HLA-G mRNA and its soluble isoforms. Objective:...
6.
Azarpira N, Aghdai M, Nikeghbalian S, Geramizadeh B, Darai M, Esfandiari E, et al.
Exp Clin Transplant
. 2013 Mar;
12(2):139-42.
PMID: 23477484
Objectives: Type 1 diabetes mellitus is an emerging epidemic worldwide and results from autoimmune destruction of insulin-producing β cells. Islet transplanting is a potential treatment for type 1 diabetes mellitus....
7.
Azarpira N, Aghdai M, Geramizadeh B, Bahador A, Ayatolahi M, Darai M
Exp Clin Transplant
. 2013 Feb;
11(1):21-6.
PMID: 23387538
Objectives: Nitric oxide is a major mediator in vascular biology and regulator of regional blood flow. Its production is catalyzed by the enzyme endothelial nitric oxide synthase. Protective actions of...
8.
Hashemi S, Ashraf M, Saboori M, Azarpira N, Darai M
Mol Biol Rep
. 2012 Oct;
39(12):10481-7.
PMID: 23073770
Hereditary hearing loss is a genetically heterogeneous disorder. Mutations in connexin 26 (CX26), are a major cause in many countries and are largely dependent on ethnic groups. The purpose of...
9.
Azarpira N, Dehghani M, Darai M
Saudi J Kidney Dis Transpl
. 2012 May;
23(3):521-5.
PMID: 22569438
We studied the correlation between changes in the serum levels of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) with complications such as acute graft versus host disease (aGVHD), veno-occlusive...
10.
Rahsaz M, Azarpira N, Nikeghbalian S, Aghdaie M, Geramizadeh B, Moini M, et al.
Exp Clin Transplant
. 2012 Feb;
10(1):24-9.
PMID: 22309416
Objectives: Tacrolimus is widely used as an immunosuppressive drug in liver transplant recipients with a narrow therapeutic range and variable individualized pharmacokinetics. Tacrolimus is a substrate of cytochrome P-450 3A...